COMMUNIQUÉS West-GlobeNewswire

-
InspireMD Announces 1-for-50 Reverse Stock Split
26/03/2019 -
Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
26/03/2019 -
Cronos Group Inc. Announces Fourth Quarter 2018 and Full Year 2018 Results
26/03/2019 -
Teleflex Publishes Inaugural Corporate Social Responsibility (CSR) Report
26/03/2019 -
BriaCell to Announce Early Efficacy Data of Lead Candidate in Combination with KEYTRUDA® at AACR Annual Meeting
26/03/2019 -
BrainStorm Announces Grant of an additional New European Patent for NurOwn®
26/03/2019 -
CampDoc and Waldo Photos Announce New Partnership for Facial Recognition Photo Sharing with Parents
26/03/2019 -
Bhang Corporation’s Scott Van Rixel and Jamie Pearson Named to High Times' Most Influential People in Cannabis
26/03/2019 -
American Addiction Centers: Fentanyl Presence Rising in Client Testing
26/03/2019 -
Autolus Therapeutics Unveils Expanded Next Generation Technology and Pipeline and Provides Key Update on AUTO3 Program in Pediatric ALL at R&D Day
26/03/2019 -
Zomedica Pharmaceuticals Corp. Announces Pricing of $3 Million Underwritten Public Offering of Common Shares
26/03/2019 -
LIDDS: NanoZolid® technology receives US patent valid until 2037
26/03/2019 -
Notice of Annual General Meeting in Immunicum AB (publ)
26/03/2019 -
Wildflower Brands Inc. (CSE : SUN) (OTCQB : WLDFF) en vedette dans la publication NetworkNewsWire sur l'industrie du CBD à base de chanvre en forte progression
26/03/2019 -
CFO of Oasmia, Anders Blom has resigned
26/03/2019 -
Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero
26/03/2019 -
Verona Pharma to Present at H.C. Wainwright Global Life Sciences Conference
26/03/2019 -
Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedback
26/03/2019 -
Nanobiotix annonce son plan d’enregistrement clinique dans les cancers de la Tête et du Cou avec NBTXR3 aux Etats-Unis à la suite du retour de la FDA
26/03/2019
Pages